New insulin pump shows promise for type 2 diabetes control

NCT ID NCT07276776

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a wearable insulin pump system (Omnipod M) in 40 adults aged 18-75 with type 2 diabetes. The goal was to see if the system helps keep blood sugar in a safe range and reduces dangerous highs and lows. Participants used the system for 6 weeks, and researchers measured time spent in low and high blood sugar levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Disease & Glandular Disease Clinic

    San Antonio, Texas, 78229, United States

  • Henry Ford Health

    Detroit, Michigan, 48202, United States

  • Joslin Diabetes

    Boston, Massachusetts, 02215, United States

  • MassResearch LLC.

    Waltham, Massachusetts, 02453, United States

  • Mountain Area Health Educational Center ( MAHEC)

    Asheville, North Carolina, 28803, United States

  • Texas Diabetes and Endocrinology (TDE)

    Austin, Texas, 78731, United States